MS Jun 2024 109.000 call
- Bloomberg
Bicara Therapeutics Picks Morgan Stanley For IPO of Up to $150 Million
(Bloomberg) -- Bicara Therapeutics is working with Morgan Stanley on a US initial public offering, people familiar with the situation said, as the market for first-time share sales is showing signs of normalizing. Most Read from BloombergBiden's Defiance Has Democrats Fearing They'll Lose White HouseBiden Asks Donors to Stick With Him After Disastrous DebateCLOs Have Too Much Money and Are Running Out of Things to BuySingapore Loses Last 18-Hole Public Golf Course to RedevelopmentGavin Newsom Is
- Business Wire
Morgan Stanley Announces 7.5 Cents Dividend Increase and Authorization of a Renewed $20 Billion Multi-Year Common Equity Share Repurchase Program
NEW YORK, June 28, 2024--Morgan Stanley (NYSE: MS) announced that it will increase its quarterly common stock dividend to $0.925 per share from the current $0.85 per share, beginning with the common stock dividend expected to be declared by the Firm’s Board of Directors in the third quarter of 2024.
- Barrons.com
Week’s Best: ETFs Win Popularity Contest
Morgan Stanley hit with cash-sweep suit. Morgan Stanley pays an interest rate of as little as 0.01% on customers’ uninvested cash in its default bank sweep program. Morgan Stanley declined to comment on the case.
